Feedback Control of Intravenous Anesthetics by Quantitative EEG

The use of a feedback system to control intravenous anesthetic drug delivery based on the spontaneous EEG requires at first mapping the anesthesia-induced EEG changes onto a figure which can be easily calculated and used for control. The power spectrum of the EEG signal has been widely investigated as a basis for the derivation of EEG parameters. The power spectrum is nothing but a distribution; thus, the derivation of spectral EEG parameters is equivalent to the derivation of descriptors of a distribution. It should, however, be mentioned here that the estimation of the power spectrum is not a unique procedure. The transformation from the time domain into the frequency domain requires a signal extending from −∞ to +∞ in time. Because an EEG epoch is finite in time, methods for extrapolating the signal to the future and into the past are required. Fourier transformation assumes that the epoch under consideration is repeated indefinitely to ±00, while other methods of power spectrum estimation, such as maximum entropy analysis [28], assume other methods of extrapolation. For the purpose of EEG monitoring during anesthesia, these differences in estimating the power spectrum are of minor importance if the EEG epoch is long enough. Figure 1 gives the scheme of an EEG power spectrum and the three monoparametric descriptors of distribution which were used. The simplest one is mean EEG frequency, defined as the mean of the power spectrum regarded as a distribution. As is known from ordinary statistics, the mean can give inappropriate measures of the center in the case of skew symmetric distributions and is, in addition, rather sensitive to outliers.

[1]  P. Parkin,et al.  Severe hypertension and raised haematocrit: unusual presentation of Guillain-Barré syndrome. , 1985, Postgraduate medical journal.

[2]  A. Burm,et al.  Pharmacodynamics of alfentanil as a supplement to nitrous oxide anaesthesia in the elderly patient. , 1988, British journal of anaesthesia.

[3]  H Schwilden,et al.  Closed-loop feedback controlled administration of alfentanil during alfentanil-nitrous oxide anaesthesia. , 1993, British journal of anaesthesia.

[4]  H. Schwilden,et al.  EEG Parameters for Evaluation of Depth of Anaesthesia , 1981 .

[5]  H. Schwilden,et al.  Pharmakokinetisch begründete Infusionsmodelle für die Narkoseführung mit Alfentanil , 1986 .

[6]  N. Goodman,et al.  Haemodynamic effects of infusions of diisopropyl phenol (ICI 35 868) during nitrous oxide anaesthesia in man. , 1983, British journal of anaesthesia.

[7]  H Schwilden,et al.  Pharmacokinetics as applied to total intravenous anaesthesia , 1983, Anaesthesia.

[8]  H. Schwilden,et al.  Closed-loop feedback control of propofol anaesthesia by quantitative EEG analysis in humans. , 1989, British journal of anaesthesia.

[9]  H Schwilden,et al.  Effective therapeutic infusions produced by closed-loop feedback control of methohexital administration during total intravenous anesthesia with fentanyl. , 1990, Anesthesiology.

[10]  E. Eger,et al.  Determination and applications of MAC. , 1980, Anesthesiology.

[11]  H. Shapiro,et al.  Automated EEG processing for intraoperative monitoring: a comparison of techniques. , 1980, Anesthesiology.

[12]  Use of the median EEG frequency and pharmacokinetics in determining depth of anaesthesia , 1989 .

[13]  C. Hug,et al.  Variable Rate Infusion of Alfentanil as a Supplement to Nitrous Oxide Anesthesia for General Surgery , 1983, Anesthesia and analgesia.

[14]  H. Schwilden,et al.  Quantitation of the EEG and pharmacodynamic modelling of hypnotic drugs: etomidate as an example. , 1985, European journal of anaesthesiology.

[15]  T. Ulrich,et al.  Maximum entropy spectral analy-sis and autoregressive decomposition , 1975 .

[16]  N. T. Smith,et al.  SPECTRAL EDGE FREQUENCY — A NEW CORRELATE OF ANESTHETIC DEPTH , 1980 .

[17]  E. Eger,et al.  A Comparative Study of Halothane and Halopropane Anesthesia: Including Method for Determining Equipotency , 1963, Anesthesiology.

[18]  D R Stanski,et al.  Plasma Concentrations of Alfentanil Required to Supplement Nitrous Oxide Anesthesia for General Surgery , 1986, Anesthesiology.

[19]  H Schwilden,et al.  Closed‐loop Feedback Control of Methohexital Anesthesia by Quantitative EEG Analysis in Humans , 1987, Anesthesiology.

[20]  H Schwilden,et al.  Quantitative EEG analysis during anaesthesia with isoflurane in nitrous oxide at 1.3 and 1.5 MAC. , 1987, British journal of anaesthesia.

[21]  H. Schwilden,et al.  Infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example. , 1985, European journal of anaesthesiology.

[22]  H Schwilden,et al.  Pharmacokinetics as applied to total intravenous anaesthesia , 1983, Anaesthesia.

[23]  H. Schwilden,et al.  Pharmacokinetic and pharmacodynamic modelling of propofol ('Diprivan') in volunteers and surgical patients. , 1985, Postgraduate medical journal.

[24]  A. Burm,et al.  Alfentanil requirement in Crohn's disease , 1989, Anaesthesia.